Market News & Trends
Evonik Achieves Major Biotech Breakthrough With a New Animal-Free & Fermentation-Based Collagen Platform
Evonik recently announced the development of an advanced collagen platform that is made via fermentation-based processes and devoid of animal- or human-derived materials…..
Tyligand Bioscience & Context Therapeutics Sign Strategic Development Agreement for Onapristone ER
Tyligand Bioscience and Context Therapeutics LLC recently announced the signing of collaboration agreements for the development, manufacturing, registration and future commercialization of….
Nurix Therapeutics Closes $120-Million Financing to Advance Targeted Protein Modulation Drug Pipeline
With the funds raised in this financing, Nurix is well positioned to bring its targeted protein modulation therapeutics into the clinic…..
Zydus & XOMA Announce Exclusive Licensing Agreement
Zydus Cadila and XOMA Corporation recently announced they have entered into a licensing agreement to advance an IL-2-based immuno-oncology (IO) drug candidate that….
DEINOVE Passes Second Milestone of the AGIR Program
DEINOVE recently announced it has successfully completed the second key milestone of the AGIR program – Antibiotics against Resistant Infectious Germs – which is supported by……
Ajinomoto Bio-Pharma Services Announces Formation of External Advisory Board
Ajinomoto Bio-Pharma Services recently announced the formation of its External Advisory Board (EAB) to provide insight into industry trends and…..
BeyondSpring Files for Patent Protection on BPI-002 for the Treatment of Viral Infections, Including COVID-19
BeyondSpring Inc. recently announced the submission of a provisional US patent application for its pipeline asset BPI-002, for methods of treating viral infections, including COVID-19,…
Menlo Therapeutics & Foamix Pharmaceuticals Complete Merger
Menlo Therapeutics Inc. recently announced the completion of its merger with Foamix Pharmaceuticals Ltd. following the satisfaction of all closing conditions required by the merger…
Retrophin Announces Enrollment of First 190 Patients in Pivotal Phase 3 Study
Retrophin, Inc. recently announced that the first 190 patients have been enrolled in the pivotal Phase 3 DUPLEX Study evaluating the safety and efficacy of…
10 Drugs in Pre-Registration Phase Have Potential to Reach Blockbuster Status by 2025
Out of all the drugs that are currently in the pre-registration phase and are expected to launch in 2020, 10 have the potential to reach…
Emergent BioSolutions Initiates Development of Plasma-Derived Product Candidates for the Treatment & Prevention of Coronavirus Disease
Emergent BioSolutions Inc. recently announced it has initiated development of two product candidates for the treatment and prevention of coronavirus disease (COVID-19). These product candidates…
Beroni Group Advances Research & Development of Medical Solution for Coronavirus (COVID-19)
Beroni Group recently announced its development of a medical solution using nanobody technology for the novel coronavirus (COVID-19) in collaboration with Tianjin University in China…
Arcturus Therapeutics & Duke-NUS Medical School Partner to Develop a COVID-19 Vaccine
Arcturus Therapeutics and Duke-NUS Medical School (Duke-NUS) recently announced their partnership to develop a Coronavirus….
PDC*line Pharma Announces First Patient Dosed With its Therapeutic Cancer Vaccine
PDC*line Pharma recently announced the first patient was dosed with its innovative medicinal product candidate PDC*lung01 in a Phase 1/2 trial in….
zPREDICTA Enters Strategic Collaboration With LabCorp
zPREDICTA, Inc. recently announce it has entered into a strategic collaboration with LabCorpto to support the adoption of….
ADMA Biologics Highlights Expanded Intellectual Property Portfolio
ADMA Biologics recently announced that it has received another Notice of Allowance from the US Patent and Trademark Office (USPTO) for a patent application related to its…..
Worldwide Research & Collaboration Needed to Combat Covid-19
In light of the coronavirus (COVID-19) outbreak, leading data and analytics company GlobalData has analyzed several of the largest COVID-19 clinical trials in terms of…
Itamar Medical & Clalit Research Institute Establish Research Collaboration
Itamar Medical Ltd. recently announced it has entered into a research collaboration agreement with Clalit Research Institute (CRI), a subsidiary of Clalit Health Services (CHS),…
TTP Enters Exclusive License Agreement With DiaSorin
TTP plc and DiaSorin have recently signed an exclusive license and technology transfer agreement. DiaSorin will combine its extensive molecular test offering with TTP’s Puckdx…
Evelo Biosciences Announces Biomarker Data Showing Drug is Orally Delivered Dual Cytokine Inhibitor for Inflammatory Diseases
Evelo Biosciences, Inc. recently announced biomarker data for EDP1815, its lead inflammation product candidate. Interim data from individuals in the ongoing Phase 1b clinical trial…
